Alcon adds to surgical portfolio

Alcon has added a range of mydriatic, cycloplegic, diagnostic and anesthetic ophthalmic surgical products, according to a press release.
These products, transferred from Alcon’s parent company, Novartis, include:
“At Alcon, we strive to provide surgeons the most complete line of ophthalmic products available — not only through innovations in technology, but now through a portfolio of mydriatic, cycloplegic, diagnostic and anesthetic products,” Brian O’Neal, Alcon’s head of marketing, US Surgical, said in the release. “With the transition of this

Full Story →